Matthias Paul Han Sim Toh
National Healthcare Group
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matthias Paul Han Sim Toh.
Diabetes Research and Clinical Practice | 2014
Charmaine S. Ng; Joyce Yu-Chia Lee; Matthias Paul Han Sim Toh; Yu Ko
BACKGROUND Diabetes mellitus (DM) is recognised as a major health problem. OBJECTIVES The aims of this study are two-fold: (1) to describe the methods used in the identified cost-of-illness (COI) studies of DM and (2) to summarise their study findings regarding the economic impact of DM. METHODS This is a systematic review of MEDLINE and Scopus journal articles reporting the cost of type 1 and/or 2 DM that were published in English from 2007 to 2011. Costs reported in the included studies were converted to US dollars. RESULTS The systematic search yielded 30 articles. The studies varied considerably in their study design, perspective and included cost categories. Estimates for the total annual costs of DM ranged from US
Value in Health | 2009
Yan Sun; Matthias Paul Han Sim Toh
141.6 million to US
Health Promotion International | 2012
Yu Ko; Joyce Yu-Chia Lee; Matthias Paul Han Sim Toh; Wern Ee Tang; Audrey Siok Ling Tan
174 billion; direct costs ranged from US
PLOS ONE | 2015
Charmaine Shuyu Ng; Matthias Paul Han Sim Toh; Yu Ko; Joyce Yu-Chia Lee
150 to US
Nephrology | 2015
Ping Tyug Loh; Matthias Paul Han Sim Toh; Joseph Antonio Molina; Anantharaman Vathsala
14,060 per patient per year (pppy) whereas indirect costs ranged from US
Vaccine | 2012
Matthias Paul Han Sim Toh; Predeebha Kannan; Yongchang Chen; Florence Liong Cheu Chng; Wern Ee Tang
39.6 to US
Journal of Diabetes | 2017
Lai Yin Wong; Matthias Paul Han Sim Toh; Linus Tham
7,164 pppy. Inpatient cost was the major contributor to direct cost in half of the studies that included inpatient costs, physician services and medications. CONCLUSION There is a considerable economic burden associated with DM. Future research should focus on improving methods of estimating costs, enhancing the interpretation of study findings and facilitating comparisons between studies.
International Journal of Stroke | 2015
Charmaine Shuyu Ng; Matthias Paul Han Sim Toh; Jiaying Ng; Yu Ko
OBJECTIVE This study aims to assess the impact of diabetes mellitus (DM) on the health-care utilization and clinical outcomes of patients with acute stroke. METHODS This is a retrospective cohort study. All patients who were admitted for the first time to one of the three public hospitals in the National Healthcare Group in Singapore from January 2005 to June 2007 with a primary diagnosis of acute stroke were included and were followed up for 1 year after the index hospitalization. The study population was divided into two groups: with DM and without DM. Both univariate and multivariate analyses were applied to compare the hospital length of stay (LOS), hospitalization costs, mortality, as well as the 1-year hospital readmissions between the DM and non-DM groups. RESULTS There were 9766 study patients, and 38.5% of them had DM. DM patients with ischemic stroke (IS) and transient ischemic attack (TIA) stayed 1-day and 0.6-day longer, and incurred 10% and 26% higher hospital cost during index admission, respectively, compared with their counterparts in the non-DM group. They also had more hospital readmission within 1 year. The mortality rate in IS patients with diabetes was 24% higher. After risk adjustment, subarachnoid hemorrhage patients with diabetes had more hospitalizations. Intracerebral hemorrhage (ICH) and IS patients in the DM group had all worse outcomes but the 1-year stroke recurrence; TIA patients with DM incurred longer LOS and hospital costs. CONCLUSION DM predicts worse clinical outcomes and higher health-care expenditures in the 1-year poststroke especially for the IS, ICH, and TIA stroke subtypes.
BMJ Open | 2015
Christine Xia Wu; Woan Shin Tan; Ryan Chor Kian See; Weichang Yu; Lynette Siang Lim Kwek; Matthias Paul Han Sim Toh; Thong Gan Chee; Gerald Seng Wee Chua
Due to the concern of equating correct pronunciation with comprehension and the differences in health care systems, existing health literacy (HL) instruments may not be appropriate for or applicable to English-speaking countries other than the USA. The purpose of this study was to develop and validate the Health Literacy Test for Singapore (HLTS), which is an adapted version of the Short-Test of Functional Health Literacy in Adults. Three hundred and two patients were interviewed and administered the HLTS, the Newest Vital Sign (NVS), a demographic questionnaire, and a knowledge test of chronic diseases. The convergent validity of HLTS was determined by examining the association between HLTS and NVS HL levels, whereas predictive validity was tested by examining the difference in knowledge of chronic conditions between the two HLTS HL (i.e. adequate and inadequate HL) groups. Bivariate correlation of HLTS HL levels with age and education was assessed to test a priori hypotheses that patients with inadequate HL were older and less educated. The results showed that HLTS displayed good internal reliability (Cronbachs alpha = 0.87). The correlation between HLTS and NVS was moderate (γ = 0.55; P = 0.005) and individuals with inadequate HL were older (P = 0.002) and less educated (P = 0.007). In addition, patients with adequate HL had a higher mean score on the chronic disease knowledge test (P = 0.036). In conclusion, the HLTS is a valid and reliable measure for assessing Singaporeans ability to read and comprehend health-related materials written in English.
Journal of Diabetes | 2012
Yee Gary Ang; Christine Xia Wu; Matthias Paul Han Sim Toh; Kee Seng Chia; Bee Hoon Heng
Due to the chronic nature of diabetes along with their complications, they have been recognised as a major health issue, which results in significant economic burden. This study aims to estimate the direct medical cost associated with type 2 diabetes mellitus (T2DM) in Singapore in 2010 and to examine both the relationship between demographic and clinical state variables with the total estimated expenditure. The National Healthcare Group (NHG) Chronic Disease Management System (CDMS) database was used to identify patients with T2DM in the year 2010. DM-attributable costs estimated included hospitalisations, accident and emergency (A&E) room visits, outpatient physician visits, medications, laboratory tests and allied health services. All charges and unit costs were provided by the NHG. A total of 500 patients with DM were identified for the analyses. The mean annual direct medical cost was found to be